BackMarinus Pharmaceuticals Overview

Marinus Pharmaceuticals Current Cash

Marinus Pharmaceuticals's current cash is $42M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$42.18M
↓ 69.96% YoYΔ $-98.25M vs prior year quarter

Peer average

Loading

Marinus Pharmaceuticals Current Cash History

Loading

Marinus Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Marinus Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Marinus Pharmaceuticals (MRNS) FAQ

Marinus Pharmaceuticals (MRNS) currently reports a current cash of $42M as of September 2024. That compares with $140M in the prior-year period — down 70.0% year over year. Use the charts on this page to explore Marinus Pharmaceuticals's current cash history and peer comparisons.

Marinus Pharmaceuticals's current cash decreased from $140M to $42M — a 70.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Marinus Pharmaceuticals reported $42M in current cash as of September 2024. That compares with $140M in the prior-year period — down 70.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Marinus Pharmaceuticals, and consider following MRNS for alerts when major investors trade the stock.

Marinus Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRNS with unrelated industries.